Neuraptive Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$5M
- Investors
-
6
Neuraptive Therapeutics General Information
Description
Developer of a therapeutic technology designed to improve the speed and quality of recovery from peripheral nerve injury. The company creates a suite of microsurgical instruments for peripheral nerve surgery after trauma or during face and body reconstructive procedures, enabling patients to rapidly recover their damaged peripheral nerve injuries and reduce their pain.
Contact Information
Website
www.neuraptive.comCorporate Office
- 851 Duportail Road
- Suite 200
- Chesterbrook, PA 19087
- United States
Corporate Office
- 851 Duportail Road
- Suite 200
- Chesterbrook, PA 19087
- United States
Neuraptive Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | $5M | Completed | Clinical Trials - Phase 3 | |||
| 5. Debt - General | 28-Aug-2024 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series B) | 14-Oct-2022 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series A) | 19-Dec-2018 | Completed | Clinical Trials - General | |||
| 2. Seed Round | 06-Sep-2017 | $1M | $1M | Completed | Clinical Trials - General | |
| 1. University Spin-Out | 01-Jan-2016 | Completed | Pre-Clinical Trials |
Neuraptive Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Neuraptive Therapeutics Comparisons
Industry
Financing
Details
Neuraptive Therapeutics Competitors (1)
One of Neuraptive Therapeutics’s competitors is Axogen, a Formerly VC-backed company based in Alachua, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Axogen | Formerly VC-backed | Alachua, FL |
Neuraptive Therapeutics Patents
Neuraptive Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025206224-A1 | Method of treating nerve injuries | Pending | 05-Jan-2024 | ||
| EP-4836791-A1 | Method of treating nerve injuries | Pending | 05-Jan-2024 | ||
| WO-2025147536-A1 | Method of treating nerve injuries | Inactive | 05-Jan-2024 | ||
| AU-2018308115-A1 | Device and method of creating a fluid containment field for administering therapeutics to a nerve | Active | 26-Jul-2017 | ||
| AU-2018308115-B2 | Device and method of creating a fluid containment field for administering therapeutics to a nerve | Active | 26-Jul-2017 | A61F2/02 |
Neuraptive Therapeutics Signals
Neuraptive Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Denniston Family Office | Family Office | Minority | ||
| Keiretsu Forum | Angel Group | Minority | ||
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Accelerator/Incubator | Minority | ||
| Central Texas Angel Network | Angel Group | Minority | ||
| New Rhein Healthcare | Venture Capital | Minority |
Neuraptive Therapeutics FAQs
-
When was Neuraptive Therapeutics founded?
Neuraptive Therapeutics was founded in 2016.
-
Where is Neuraptive Therapeutics headquartered?
Neuraptive Therapeutics is headquartered in Chesterbrook, PA.
-
What is the size of Neuraptive Therapeutics?
Neuraptive Therapeutics has 6 total employees.
-
What industry is Neuraptive Therapeutics in?
Neuraptive Therapeutics’s primary industry is Surgical Devices.
-
Is Neuraptive Therapeutics a private or public company?
Neuraptive Therapeutics is a Private company.
-
What is Neuraptive Therapeutics’s current revenue?
The current revenue for Neuraptive Therapeutics is .
-
How much funding has Neuraptive Therapeutics raised over time?
Neuraptive Therapeutics has raised $38M.
-
Who are Neuraptive Therapeutics’s investors?
Denniston Family Office, Keiretsu Forum, Ben Franklin Technology Partners of Southeastern Pennsylvania, Central Texas Angel Network, and New Rhein Healthcare are 5 of 6 investors who have invested in Neuraptive Therapeutics.
-
Who are Neuraptive Therapeutics’s competitors?
Axogen is a competitor of Neuraptive Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process